The most widely used treatment remains the use of corticosteroids and angiotensin-converting enzyme inhibitors to control the symptoms of cardiomyopathy and rehabilitation and symptomatic support to prolong patient life (1). The gene discussed is ACE; the disease is cardiomyopathy.